Prostate Cancer Not More Common in Hemophiliacs
Prostate Cancer Not More Common in Hemophiliacs
February 03, 2015
Prostate Cancer Not More Common in Hemophiliacs
Hemophilia patients have a higher incidence of cancers, but not prostate cancer.
Patients with hemophilia have a higher incidence of cancers overall compared with the general population, but notprostate cancer (PCa), according to a new study.
Yung-Chieh Huang, MD, of the Taichung Veterans General Hospital in Taichung, Taiwan, and colleagues looked at the incidence of various cancers and associated survival among 1,054 patients with hemophilia and 10,540 age-and gender-matched healthy individuals from the general population. The cumulative incidences of cancer were 4.7% among the patients with hemophilia and 1.9% in the general population, the researchers reported online ahead of print in theAmerican Journal of Hematology. The investigators found no significant differences between the 2 groups in the incidences of PCa, lung, or colorectal cancer or in survival rate.
Hepatocellular carcinoma was the major type of cancer observed in the hemophiliacs, occurring in 17 patients.
Compared with the general population, patients with hemophilia were significantly younger at the time of cancer diagnosis (45.1 vs. 57.2 years old) and had fewer comorbidities.
RELATED
PCa Family History Screening May Decrease Mortality
Quarter of Metastatic PCa Patients Had Synchronous Cancer
Prostate Cancer Linked to Increased Colorectal Cancer Risk
Important Prostate Cancer Advances of the Last 10 Years
Biologic Agents Associated with High Risk of HBV Flares in Psoriasis, Other Conditions
RA, Psoriasis Medications May Increase Risk of Hepatitis B Flares
Big Data, Big Psychiatry — Big Potential?
RELATED ARTICLES
- PCa Family History Screening May Decrease Mortality
- VA Study Reveals No Race Disparities in Prostate Cancer Outcomes
- Overweight Men Face Higher Risk of Aggressive Prostate Cancer (PCa)
RELATED TOPICS
RELATED LINKS
RELATED SLIDESHOWS
Is “Fusion” Technology Heralding the “Anatomic” Age for Prostate ….
XOFIGO® (radium Ra 223 dichloride)